Gonococcal antimicrobial susceptibility surveillance in Europe 2009
Since 2009, the European Centre for Disease Prevention and Control has coordinated the enhanced surveillance of sexually transmitted infections in Europe.
Gonococcal antimicrobial susceptibility surveillance in Europe – 2010
In 2010, 21 EU/EEA Member States participated in the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), testing a total of 1766 isolates.
Molecular typing of Neisseria gonorrhoeae
In 2011, a pilot study was undertaken to assess the public health benefit of molecular surveillance for gonorrhoea in 21 EU/EEA countries. A total of 1 066 isolates collected under the 2010 European gonococcal antimicrobial surveillance programme were typed and 406 sequence types identified, with considerable diversity among countries.
Gonococcal antimicrobial susceptibility surveillance in Europe 2011
This report presents the results from the 2011 gonococcal antimicrobial susceptibility surveillance programme (Euro-GASP) and a summary of the second distribution from the 2011 external quality assurance (EQA) scheme.
STI and HIV prevention in men who have sex with men in Europe
This report gives an overview of the current status of STI and HIV among men who have sex with men (MSM) in EU/EEA countries. It reviews HIV and STI prevention interventions targeted at MSM, and the evaluations of those interventions.
Euro-GASP external quality assessment (EQA) scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing 2016
The EQA scheme is available to all laboratories in the STI surveillance network, which are mainly national reference laboratories or provide expert services (national or regional) in respect to N. gonorrhoeae diagnostics and antimicrobial susceptibility testing.
Gonococcal antimicrobial susceptibility surveillance in Europe, 2015
The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) follows a decentralised and centralised testing model. In 2015, 24 EU/EEA Member States participated in Euro-GASP, 17 through decentralised testing.
European Gonococcal Antimicrobial Surveillance Programme external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing, 2017
An EQA scheme for antimicrobial susceptibility testing in Neisseria gonorrhoeae has been available to laboratories participating in ECDC’s European Sexually Transmitted Infections (STI) surveillance network since 2010. This is the third EQA to be published on antimicrobial susceptibility testing in Neisseria gonorrhoeae.
Molecular typing of Neisseria gonorrhoeae – a study of 2013 isolates
This report describes the second molecular typing survey of N. gonorrhoeae across the EU/EEA and provides recent information on NG-MAST STs/Gs and genotypes based on WGS circulating in 21 EU/EEA Member States.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA
This report presents the main findings of an ECDC project to assess the burden of infectious diseases among migrants in the EU/EEA based on available data for specific diseases: human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B, hepatitis C, gonorrhoea, syphilis, measles and rubella, malaria and Chagas disease.